Department of Preventive Medicine, Shantou University Medical College, Shantou, Guangdong Province, China.
PLoS One. 2019 Jul 10;14(7):e0219611. doi: 10.1371/journal.pone.0219611. eCollection 2019.
At present, the management of nasopharyngeal carcinoma (NPC) is mainly based on radiotherapy, but there are many radiation delivery techniques such as intensity-modulated radiotherapy (IMRT) and 2-dimensional radiotherapy (2D-RT).
We searched all the eligible studies through the PubMed, Cochrane Library, Medline, and Embase. The endpoint events in meta-analysis were overall survival (OS), tumor local control including local-regional free survival (LRFS), progression-free survival (PFS), and distant metastasis-free survival (DMFS), and late toxicities.
A total of ten publications met the criteria and were identified through searches of the databases and references. We included 13304 patients in the meta-analysis, of whom 5212 received IMRT and 8092 were allocated to 2D-RT alone group. Compared with 2D-RT treatment, the IMRT group was associated with a better 5-year OS (OR = 1.70; 95% CI = 1.36-2.12), LRFS (OR = 2.08; 95% CI = 1.82-2.37), and PFS (OR = 1.40; 95% CI = 1.26-1.56). Additionally, the incidence of late toxicities such as late xerostomia (OR = 0.21; 95% CI = 0.09-0.51), trismus (OR = 0.16; 95% CI = 0.04-0.60), and temporal lobe neuropathy (TLN) (OR = 0.40; 95% CI = 0.24-0.67) for NPC patients in IMRT group were significantly lower than 2D-RT.
The meta-analysis demonstrates that IMRT provides improved long-term tumor overall survival and local control including LRFS and PFS. Additionally, IMRT yields a lower incidence of late toxicities induced by irradiation in NPC patients. Compared to 2D-RT, IMRT may be an effective treatment for patients with NPC. Further intensive studies should be pursued to examine the association.
目前,鼻咽癌(NPC)的治疗主要基于放疗,但有许多放射治疗技术,如调强放疗(IMRT)和二维放疗(2D-RT)。
我们通过 PubMed、Cochrane 图书馆、Medline 和 Embase 搜索所有合格的研究。荟萃分析的终点事件包括总生存期(OS)、肿瘤局部控制包括局部区域无复发生存(LRFS)、无进展生存期(PFS)和无远处转移生存期(DMFS)以及晚期毒性。
通过数据库和参考文献的搜索,共找到 10 篇符合标准的文献。我们对 13304 名患者进行了荟萃分析,其中 5212 名患者接受了 IMRT,8092 名患者单独接受了 2D-RT 治疗。与 2D-RT 治疗相比,IMRT 组患者 5 年 OS(OR=1.70;95%CI=1.36-2.12)、LRFS(OR=2.08;95%CI=1.82-2.37)和 PFS(OR=1.40;95%CI=1.26-1.56)均有显著改善。此外,IMRT 组患者晚期毒性(如口干症、张口困难和颞叶神经病变)的发生率明显低于 2D-RT 组,如口干症(OR=0.21;95%CI=0.09-0.51)、张口困难(OR=0.16;95%CI=0.04-0.60)和颞叶神经病变(OR=0.40;95%CI=0.24-0.67)。
荟萃分析表明,IMRT 可提高 NPC 患者的长期肿瘤总生存率和局部控制率,包括 LRFS 和 PFS。此外,IMRT 可降低 NPC 患者放疗引起的晚期毒性发生率。与 2D-RT 相比,IMRT 可能是 NPC 患者的一种有效治疗方法。需要进一步进行深入研究来检验这种关联。